Asthmanex Report for Patients Like You

What is Asthmanex?

An example of Asthmanex

Asthmanex is a brand name for the drug mometasone furoate, a corticosteroid used in the treatment of asthma. Asthmanex is a brand name owned by Schering.

Reported Purpose & Perceived Effectiveness

Reasons and Perceived effectiveness
			Perceived Effectiveness
Purpose	# of patients	# of patients with evaluations	Major	Moderate	Slight	None	Can’t tell
Asthma	4	2
Difficulty breathing at night	1	0
Bronchospasm	1	1

See all 4 patients currently taking Asthmanex

Mouse over the table for more information

Reported Side Effects

Side effects as an overall problem

Severe	0
Moderate	0
Mild	0
None	3

Reported Dosages

2mcg as needed	4 mcg daily	220 mcg daily
1	1	2

Reported Stop Reasons

Why Patients Stopped Taking Asthmanex (multiple reasons could be selected)
Reason	# Patients	Percentage of patients
Did not seem to work	2
Doctor's advice	1

See all 3 patients who’ve stopped taking Asthmanex

Reported Duration See details about how long patients take this treatment ▼ Reported Duration Hide details ▲

Currently Taking Asthmanex

A bar graph

0-1 month	1-3 months	3-6 months	6 months-1year	1-2 years	2 years or more
0	0	0	0	1	0

Stopped Taking Asthmanex

A bar graph

0-1 month	1-3 months	3-6 months	6 months-1year	1-2 years	2 years or more
0	0	1	1	1	0

Reported Adherence, Burden & Cost See details from patient evaluations ▼

Adherence

Taking treatment as prescribed

Adherence of Asthmanex

Always	1	33%
Usually	1	33%
Sometimes	1	33%
Never	0	0%

Burden

Difficulty being on treatment

Burden of Asthmanex

Very	0	0%
Somewhat	0	0%
A little	1	33%
Not at all	2	67%

Cost

Paid out of pocket

Cost of Asthmanex

$200+	0	0%
$100-199	0	0%
$50-99	0	0%
$25-49	0	0%
< $25	1	100%